NVEC.NASDAQNve CORP /NEW/

10-Q: NVE Corporation Reports Third Quarter Fiscal 2024 Results Amidst Revenue Decline

Sentiment:

Quarterly Report


NVE Corporation's third quarter fiscal 2024 results show a decrease in revenue primarily due to lower product sales, partially offset by increased contract research and development revenue.

Worse than expectedThe company's revenue decreased by 9% for the quarter and 11% for the nine-month period, indicating worse than expected performance.Net income decreased by 1% for the quarter and 8% for the nine-month period, reflecting a decline in profitability.

Summary

  • NVE Corporation's total revenue for the quarter ended December 31, 2023, decreased by 9% compared to the same quarter in the previous year, totaling $6.76 million.
  • The decrease in revenue was primarily driven by a 12% decline in product sales, which was partially offset by a 94% increase in contract research and development revenue.
  • For the nine months ended December 31, 2023, total revenue decreased by 11% to $22.72 million compared to the same period in 2022.
  • Net income for the quarter was $4.18 million, a slight decrease of 1% compared to the $4.23 million reported in the same quarter of the previous year.
  • Net income for the nine-month period was $13.31 million, an 8% decrease compared to $14.46 million in the same period of the previous year.
  • The company's cash and cash equivalents increased to $4.68 million as of December 31, 2023, from $1.67 million as of March 31, 2023.
  • The company declared a cash dividend of $1.00 per share for the quarter, consistent with previous quarters.

Sentiment

Score: 5

Explanation: The document presents mixed results with a decrease in revenue and net income, but also highlights positive aspects such as increased contract research revenue and strong cash position. The overall sentiment is neutral to slightly negative due to the revenue decline.

Positives

  • Contract research and development revenue increased significantly by 94% in the third quarter of fiscal 2024.
  • Total expenses decreased by 16% for the third quarter of fiscal 2024.
  • Interest income increased by 21% for the third quarter of fiscal 2024.
  • The company's cash and cash equivalents increased by $3.01 million during the first nine months of fiscal 2024.
  • The company continues to generate positive cash flow from operations.
  • The company maintains a strong balance sheet with significant marketable securities holdings.

Negatives

  • Total revenue decreased by 9% for the quarter and 11% for the nine-month period.
  • Product sales decreased by 12% in the third quarter of fiscal 2024.
  • Net income decreased by 1% for the quarter and 8% for the nine-month period.
  • Accounts receivable decreased by $4.27 million during the first nine months of fiscal 2024.
  • Inventories increased by $0.93 million during the first nine months of fiscal 2024.
  • The company experienced a decrease in purchases by existing customers, particularly in the defense industry.

Risks

  • The company is reliant on several large customers for a significant percentage of revenue.
  • The company is dependent on critical suppliers and packaging vendors.
  • There are uncertainties related to the economic environments in the industries the company serves.
  • There are risks of credit losses on accounts receivable.
  • The company's future stock repurchases and dividend payments are subject to various factors and may be modified or discontinued.
  • The company's Supplier Partnering Agreement with Abbott Laboratories expires on December 31, 2024, and may not be renewed.

Future Outlook

The company's future performance is subject to various factors, including customer demand, economic conditions, and the company's ability to manage expenses and investments. Future dividends are subject to Board approval and may be modified or discontinued.

Management Comments

  • Management noted that the decrease in product sales was primarily due to decreased purchases by existing customers, particularly in the defense industry, and a semiconductor industry downturn.
  • Management stated that the increase in contract research and development revenue was due to new customer-funded research and development contracts.
  • Management indicated that the decrease in research and development expense was primarily due to the redeployment of resources to customer-funded research and development projects.
  • Management mentioned that the increase in interest income was due to increased yields on securities purchased after December 31, 2022.
  • Management stated that the decrease in the effective tax rate was primarily due to an increase in certain tax deductions.

Industry Context

The company's performance is affected by the semiconductor industry downturn and decreased purchases in the defense industry, reflecting broader economic trends impacting these sectors. The increase in contract research and development revenue suggests a strategic shift towards customer-funded projects.

Comparison to Industry Standards

  • NVE's reliance on a few large customers is a common risk in the semiconductor industry, where customer concentration can lead to revenue volatility.
  • The company's high percentage of assets in marketable securities is unusual compared to many manufacturing companies, suggesting a conservative financial strategy.
  • The decrease in product sales aligns with the broader semiconductor industry downturn, which has impacted many companies in the sector.
  • The increase in contract research and development revenue is a positive sign, indicating the company's ability to adapt to changing market conditions and secure new revenue streams.
  • The company's consistent dividend payout is a positive signal for investors, but the sustainability of this payout depends on future financial performance.

Stakeholder Impact

  • Shareholders will be impacted by the decrease in revenue and net income, but also by the continued dividend payments.
  • Employees may be affected by changes in staffing and compensation.
  • Customers may experience changes in product availability and pricing.
  • Suppliers may be impacted by changes in the company's purchasing patterns.
  • Creditors will be impacted by the company's financial performance and ability to meet its obligations.

Next Steps

  • The company will continue to monitor market conditions and adjust its strategies as needed.
  • The company will continue to evaluate its stock repurchase program and dividend policy.
  • The company will focus on securing new customer contracts and managing expenses.

Key Dates

DateDescription
2009-01-21The company announced the initial stock repurchase program.
2015-08-27The company announced an increase to the stock repurchase program.
2023-03-31End of the company's fiscal year 2023.
2023-06-30End of the first quarter of fiscal year 2024.
2023-09-30End of the second quarter of fiscal year 2024.
2023-12-31End of the third quarter of fiscal year 2024 and the period covered by this report.
2024-01-17The company announced a cash dividend of $1.00 per share.
2024-01-29Record date for the declared cash dividend.
2024-02-28Payment date for the declared cash dividend.
2024-12-31Expiration date of the Supplier Partnering Agreement with Abbott Laboratories.
2026-03-31Expiration date of the company's current lease.

Keywords

spintronics, sensors, couplers, marketable securities, revenue, net income, dividends, research and development, semiconductor, defense industry

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.